Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
20%
Anticoagulant Agent
41%
Antiinfective Agent
33%
Apigenin
16%
Atrial Fibrillation
33%
Biological Marker
6%
Bleeding
16%
Cardiovascular Disease
33%
Chronic Inflammation
33%
Clinical Pharmacy
16%
Combination Therapy
43%
Comorbidity
31%
Cross-Sectional Study
100%
Diabetes Mellitus
11%
Diet Induced Obesity
33%
Disease Duration
16%
Diseases
10%
Distress Syndrome
33%
Endothelial Dysfunction
20%
Etanercept
33%
Heart Disease
7%
Heart Infarction
33%
Heavy Metal
11%
Inflammation
40%
Insulin Resistance
33%
Intestine Flora
33%
Ixekizumab
6%
Lipopolysaccharide
13%
Medication Error
24%
Metabolic Disorder
33%
Microflora
33%
Myeloid Differentiation Factor 88
33%
Pharmaceutical Care
33%
Pharmacotherapy
67%
Pharmacy Practice
33%
Protein Ligand
6%
Receptor
6%
Remission
9%
Resveratrol
27%
Risankizumab
27%
Rivaroxaban
16%
Therapeutic Effect
6%
Toll Like Receptor 4
33%
Tumor Necrosis Factor
14%
Tumor Necrosis Factor Inhibitor
33%
Ubidecarenone
33%
Ustekinumab
67%
Vascular Disease
33%
Warfarin
50%
Wistar Rat
6%
Medicine and Dentistry
Antiinfective Agent
33%
Blood Vessel Injury
6%
Cardiovascular System
33%
Chronic Disease
33%
Chronic Inflammation
33%
Combination Therapy
43%
Comorbidity
20%
Crohn's Disease
33%
Cross Sectional Study
40%
Diet Induced Obesity
33%
Disease Duration
13%
Drug Therapy
33%
Endothelial Dysfunction
20%
Gut Microbiota
33%
Inferential Statistics
6%
Insulin Resistance
33%
Insulin Sensitivity
33%
Lipopolysaccharide
13%
Logistic Regression Analysis
11%
Medication Error
24%
Metabolic Disorder
33%
Metabolite
33%
Multivariate Analysis
6%
Odds Ratio
9%
Patient Care
33%
Pattern Recognition Receptor
6%
Primary Health Care
33%
Protein-Ligand Interaction
6%
Quality of Life
33%
Resveratrol
27%
Stilbene
33%
Tumor Necrosis Factor
14%
Univariate Analysis
13%
Water-Electrolyte Imbalance
33%
Nursing and Health Professions
Acute Coronary Syndrome
33%
Amoxicillin
5%
Antiinfective Agent
33%
Antimicrobial Stewardship
5%
Chronic Disease
33%
Clavulanic Acid
5%
Combination Therapy
33%
Comorbidity
25%
Counseling
8%
Cross-Sectional Study
99%
Disease Duration
16%
Drug Therapy
42%
Health Care
16%
Health Care Facility
8%
Health Care Personnel
22%
Healthcare System
5%
Inferential Statistics
8%
Literature Review
5%
Logistic Regression Analysis
8%
Medication Compliance
25%
Medication Error
28%
Multivariate Analysis
8%
Patient Care
33%
Percutaneous Coronary Intervention
7%
Practice Guideline
5%
Primary Health Care
33%
Quality of Life
67%
Quality of Life
7%
Telemedicine
16%
Univariate Analysis
16%
